These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15690980)

  • 1. Cytotoxic immune response to a xenogeneic bioartificial liver.
    Nyberg SL; Amiot B; Hardin J; Baskin-Bey E; Platt JL
    Cell Transplant; 2004; 13(7-8):783-91. PubMed ID: 15690980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane pore size impacts performance of a xenogeneic bioartificial liver.
    Matsushita T; Amiot B; Hardin J; Platt JL; Nyberg SL
    Transplantation; 2003 Nov; 76(9):1299-305. PubMed ID: 14627907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane barrier of a porcine hepatocyte bioartificial liver.
    Nyberg SL; Yagi T; Matsushita T; Hardin J; Grande JP; Gibson LE; Platt JL
    Liver Transpl; 2003 Mar; 9(3):298-305. PubMed ID: 12619028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of membrane molecular weight cutoff on performance of a novel bioartificial liver.
    Shi XL; Zhang Y; Han B; Gu JY; Chu XH; Xiao JQ; Ren HZ; Tan JJ; Ding YT
    Artif Organs; 2011 Mar; 35(3):E40-6. PubMed ID: 21371057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for Galalpha(1-3)Gal expression on primary porcine hepatocytes: implications for bioartificial liver systems.
    van de Kerkhove MP; Germans MR; Deurholt T; Hoekstra R; Joziasse DH; van Wijk AC; van Gulik TM; Chamuleau RA; Roos A
    J Hepatol; 2005 Apr; 42(4):541-7. PubMed ID: 15763340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of membrane molecular weight cutoff on a novel bioartificial liver.
    Zhang Y; Shi XL; Han B; Gu JY; Chu XH; Xiao JQ; Ren HZ; Tan JJ; Ding YT
    Artif Organs; 2012 Jan; 36(1):86-93. PubMed ID: 21819437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an ex vivo model of pig to human xenotransplantation.
    Baquerizo A; Mhoyan A; Kearns-Jonker M; Arnaout WS; Shackleton C; Busuttil RW; Demetriou AA; Cramer DV
    Transplantation; 1999 Jan; 67(1):5-18. PubMed ID: 9921790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of human preformed antibody targets in GTKO pigs.
    Burlak C; Wang ZY; Chihara RK; Lutz AJ; Wang Y; Estrada JL; Tector AJ
    Xenotransplantation; 2012; 19(2):92-101. PubMed ID: 22497511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioartificial liver with whole blood perfusion.
    Ueda Y; Iwata H; Paek HJ; Ko IK; Shimooka Y; Katsura N; Ikai I; Yamaoka Y; Ikada Y
    ASAIO J; 2003; 49(4):401-6. PubMed ID: 12918581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosafety evaluation of a multilayer flat-plate bioartificial liver.
    Zhang Y; Shi XL; Han B; Gu JY; Chu XH; Xiao JQ; Ren HZ; Tan JJ; Ding YT
    Am J Med Sci; 2012 Jun; 343(6):429-34. PubMed ID: 22008783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internal bioartificial liver with xenogeneic hepatocytes prevents death from acute liver failure: an experimental study.
    Roger V; Balladur P; Honiger J; Baudrimont M; Delelo R; Robert A; Calmus Y; Capeau J; Nordlinger B
    Ann Surg; 1998 Jul; 228(1):1-7. PubMed ID: 9671059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological consequences of the use of xenogeneic hepatocytes in a bioartificial liver for acute liver failure.
    te Velde AA; Flendrig LM; Ladiges NC; Chamuleau RA
    Int J Artif Organs; 1997 Apr; 20(4):229-33. PubMed ID: 9195241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological analysis in xenogeneic fetal porcine liver transplantation into a beagle.
    Shimura T; Takebe K; Kano K; Suzuki H; Hagihara M; Asao T; Kuwano H
    Hepatogastroenterology; 2000; 47(31):251-5. PubMed ID: 10690617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoprotection of xenocytes in a hollow fiber bioartificial liver.
    Nyberg SL; Platt JL; Shirabe K; Payne WD; Hu WS; Cerra FB
    ASAIO J; 1992; 38(3):M463-7. PubMed ID: 1457903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steering orally induced deviation of xenogeneic immunity with exogenous cytokines in rats fed porcine proteins.
    Bridle BW; Wilkie BN; Jevnikar AM; Mallard BA
    Transpl Immunol; 2009 Dec; 22(1-2):32-7. PubMed ID: 19748586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal tissue engineered liver-assist devices.
    Tzanakakis ES; Hess DJ; Sielaff TD; Hu WS
    Annu Rev Biomed Eng; 2000; 2():607-32. PubMed ID: 11701525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenogeneic direct hemoperfusion using whole swine liver for liver failure in dogs.
    Naruse K; Sakai Y; Natori T; Guo L; Shindoh J; Iida Y; Michishita K; Karasawa Y; Kojima K; Makuuchi M
    J Surg Res; 2003 May; 111(2):229-35. PubMed ID: 12850467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Nafamostat Mesilate for improving the performance of a bioartificial liver using porcine hepatocytes.
    Fujioka H; Eguchi S; Sugiyama N; Kawazoe Y; Kawashita Y; Kamohara Y; Azuma T; Furui J; Kanematsu T
    Int J Artif Organs; 1999 Jul; 22(7):505-10. PubMed ID: 10493559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional evaluation of a new bioartificial liver system in vitro and in vitro.
    Chen Z; Ding YT
    World J Gastroenterol; 2006 Feb; 12(8):1312-6. PubMed ID: 16534893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigs.
    Li LJ; Du WB; Zhang YM; Li J; Pan XP; Chen JJ; Cao HC; Chen Y; Chen YM
    J Hepatol; 2006 Feb; 44(2):317-24. PubMed ID: 16356580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.